Zefeng Lai | Drug Delivery Systems | Excellence in Pharmaceutical Innovation Award

Published on by Top Pharmaceutical

Prof. Dr. Zefeng Lai | Drug Delivery Systems | Excellence in Pharmaceutical Innovation Award

Guangxi Medical University | China

Prof. Dr. Zefeng Lai is a leading figure in the field of pharmaceutical science, recognized for his pioneering work in nanomedicine, drug delivery, and nanotoxicology. He serves as a Professor of Pharmaceutical Science at the School of Pharmacy, Guangxi Medical University, Nanning, China, where he has made outstanding contributions to biomedical research and academic development. Having earned his BSc and PhD from the State Key Laboratory of Crystal Materials, Shandong University, and completed postdoctoral research in Drug Delivery and Biomedical Effects of Nanomaterials, Dr. Lai’s expertise integrates material chemistry with pharmacological innovation to enhance therapeutic outcomes.His research explores the mechanisms and biomedical applications of carbon-based nanodrug carriers, focusing on their transcytosis, biodistribution, and immunological effects. He has led multiple high-impact national and provincial projects, including investigations into mesona chinensis polysaccharides, fibrinolytic enzymes from marine sources, and liver-targeted nanocarriers. His work on the biotoxicity of carboxylated single-walled carbon nanotubes using zebrafish and mammalian models has been particularly influential, advancing the global understanding of nanomaterial safety in pharmaceutical formulations.Prof. Lai’s scholarly influence is reflected in his strong research metrics, with 293 citations across 279 documents, based on 19 published papers, and an impressive h-index of 10, demonstrating his consistent impact and the recognition of his contributions by the global scientific community.His groundbreaking publications demonstrate his multidisciplinary research vision. His paper Photothermal Therapeutic Gold Nanoparticles Loaded with PD-L1 siRNA Enhanced Killing of NSCLC Cells by Immune Cells presents a novel nanoplatform integrating photothermal therapy and immunomodulation for non-small cell lung cancer treatment. His work Immunogenic Nano-Phthalocyanine Enables Oxygen-Economic Photodynamic Therapy for Hepatocellular Carcinoma introduces a new generation of oxygen-efficient nanotherapeutics for liver cancer. Other notable studies include Effect of Carboxylated Single-Walled Carbon Nanotubes on the Development and Morphology of Zebrafish Embryos, High Throughput CircRNA Sequencing Analysis Reveals Novel Insights into the Mechanism of Nitidine Chloride against Hepatocellular Carcinoma, and Toxic Effect of Long-Term Intravenous Injection of Carboxylated Single-Walled Carbon Nanotubes on Kidney in Rats. His research on Nitidine Chloride Induced Colorectal Cancer HT29 Cells Apoptosis Through the Cytochrome c-Mediated Mitochondrial Pathways and Long-Term Intravenous Administration of Carboxylated Single-Walled Carbon Nanotubes Induces Persistent Accumulation in the Lungs and Pulmonary Fibrosis via the NF-κB Pathway underscores his deep engagement with molecular pharmacology and nanotoxicology.

Profile: Scopus

Featured Publications

Lai, Z., Liu, Y., He, L., Wang, X., Zhang, H., & Zhao, J. (2023). Immunogenic nano-phthalocyanine enables oxygen-economic photodynamic therapy for hepatocellular carcinoma. Biomaterials, 295, 121992.

Hui Li | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hui Li | Drug Delivery Systems | Best Researcher Award

Woosuk University | South Korea

Dr. Hui Li is a distinguished medical scientist and otolaryngologist whose work bridges clinical medicine, translational research, and pharmaceutical innovation. He earned his Ph.D. in Translational Medicine from Seoul National University College of Medicine in Korea, where his research focused on the molecular mechanisms underlying hearing loss and radiation-induced cellular changes. Prior to his doctoral training, he completed both his Master’s and Bachelor’s degrees in Clinical Medicine from Yanbian University of Medicine in China, establishing a strong foundation in clinical diagnostics, therapeutic approaches, and patient-centered medical care.Dr. Li’s professional journey reflects an impressive progression from clinical expertise to cutting-edge biomedical research. He began his career as a medical doctor and otolaryngologist at Yanbian Yongjeong National Hospital, where he honed his clinical acumen in diagnosing and treating ear, nose, and throat disorders. His clinical excellence led him to serve as a resident and research fellow in the Department of Otolaryngology at the Affiliated Hospital of Yanbian University of Medicine, where he began integrating research into his clinical practice. He later worked as a specialist at the Yanbian National Ophthalmology & Otolaryngology Hospital, focusing on complex cases of auditory and vestibular dysfunction. These formative years in medical practice equipped him with invaluable clinical insight that continues to inform his research in translational medicine and pharmacotherapeutics.Dr. Li transitioned into academic research with his appointment as a doctoral researcher at the Department of Translational Medicine (Otolaryngology) at Seoul National University College of Medicine. There, he conducted pivotal studies on novel therapeutic delivery systems, inner ear protection mechanisms, and the molecular pathways involved in hearing impairment. His research excellence earned him postdoctoral appointments at the Cancer Research Institute within the same university, where he explored immune-modulatory effects of radiotherapy and the potential of macrophage polarization in mitigating cancer progression. Currently, he serves as a Postdoctoral Research Fellow at the Laboratory of Biopharmaceutics, Industry-Academia Cooperation Foundation, Woosuk University, Korea, where he investigates advanced drug formulations, biopharmaceutical delivery mechanisms, and the translational potential of controlled-release therapeutics.

Profile: Scopus

Featured Publications

Li, J., Wang, H., Zhang, Y., & Chen, L. (2022). Comprehensive intervention and effect of martial arts routines on children with autism. Journal of Environmental and Public Health, 2022.

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Prof Luisa De Cola, University of Milan and Mario Negri Institute, Italy

Prof. Luisa De Cola is an accomplished chemist known for her interdisciplinary research in supramolecular and materials chemistry, with applications in biomedical fields. She holds a Laurea in Chemistry from the University of Messina and has held prestigious positions at institutions like the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at Istituto Mario Negri, Milan. With over 400 published papers and 42 patents, she has received numerous awards, including the 2020 Gold Medal “Giulio Natta” and 2014 Chevalier de la Légion d’Honneur. 🏅🔬💡

Publication Profile

Google Scholar

Education

Prof. Luisa De Cola, a renowned scientist, earned her Laurea in Chemistry from the University of Messina in 1983. She has held various prestigious academic roles, including Post-doctoral Fellow at Virginia Commonwealth University, and visiting scientist positions at UCLA, Harvard, and MIT. From 1986 to 1990, she worked as a researcher at the National Research Council in Bologna. She later served as a Full Professor at the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at the Mario Negri Institute. 🧪🔬🌍

Experience

Prof. Luisa De Cola is a renowned academic and researcher currently serving as a Full Professor at the University of Milan, Italy, since 2020. She is also the Director of the “Materials for Health” unit at Istituto di Ricerche Farmacologiche Mario Negri in Milan. Her distinguished career includes previous roles at prestigious institutions such as the University of Amsterdam, University of Münster, and University of Strasbourg. Prof. De Cola has held notable positions, including chairing molecular photonic materials and nanoelectronics. Her research contributions span nanoelectronics, nanophotonics, and biomaterials. 🌍📚🔬👩‍🔬

Research achievements

Prof. Luisa De Cola’s research is known for its multidisciplinary approach, driven by curiosity and fundamental exploration, often with practical applications. Her work spans supramolecular and material chemistry, focusing on functional luminescent and electro-luminescent assemblies, optical and electroluminescent devices, and dynamic (breakable) materials for biomedical applications. With over 400 published papers in peer-reviewed journals (H-index = 88, over 27,000 citations on Scopus), her research has been featured in prestigious journals like Nature and Nature Chemistry. Her contributions continue to shape innovations in materials science and biomedicine. 🌟🧪🔬📚💡💉

Peer recognition

Prof. Luisa De Cola is a distinguished chemist, awarded numerous prestigious prizes throughout her career. Her accolades include the 1993 Chemistry Prize from the Accademia di Scienze Fisiche e Matematiche di Napoli, the 1995 Federchimica National Prize, and the 2009 European Research Council Advanced Grant Award (Magic). In 2011, she received the IUPAC Prize for distinguished women in chemistry, followed by the 2014 Chevalier de la Légion d’Honneur. Other honors include the 2019 Izatt–Christensen Award, 2020 Giulio Natta Gold Medal, and the 2024 Centenary Prize for Chemistry and Communication. She is also an Honorary Professor at Tianjin University and a Doctor Honoris Causa from Universidad Internacional Menéndez Pelayo. 🏆🔬🎖️🌟

Research Focus

Prof. Luisa De Cola’s research focuses on advanced materials, particularly in the development of luminescent and electrochemical systems for various applications. Her work involves the synthesis and characterization of ruthenium and osmium complexes, often in multi-component systems, exploring their electrochemical behavior, absorption spectra, and photoinduced processes. She investigates biomimetic self-assembly for imaging applications, the creation of highly luminescent lanthanide complexes, and photoinduced energy and electron transfer in dinuclear complexes. Her studies have applications in photonic devices, electroluminescence, and molecular imaging. Her work intersects chemistry, material science, and biological applications. 🔬💡🔋✨

Publication Top Notes

Ruthenium (II) and osmium (II) bis (terpyridine) complexes in covalently-linked multicomponent systems: synthesis, electrochemical behavior, absorption spectra, and …

Controlling and imaging biomimetic self-assembly

White‐light emission from an assembly comprising luminescent iridium and europium complexes

Highly luminescent, triple-and quadruple-stranded, dinuclear Eu, Nd, and Sm (III) lanthanide complexes based on bis-diketonate ligands

When self-assembly meets biology: luminescent platinum complexes for imaging applications

Photoinduced energy and electron transfer processes in rigidly bridged dinuclear Ru/Os complexes

Electroluminescent device with reversible switching between red and green emission